Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01230515 · ClinicalTrials.gov registry record

Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol

A clinical trial of Cancer Pain, sponsored by Vanderbilt-Ingram Cancer Center.

Completed
Registry status
65
Enrollment target
1
Study location

NCT01230515 is a study of Cancer Pain that has completed, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 65 participants, below the 158-participant average among 15 other Cancer Pain trials with a reported enrollment target (59% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01230515, a study of Cancer Pain, has completed, sponsored by Vanderbilt-Ingram Cancer Center.

COMPLETED
Registry status
65 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive preliminary efficacy data.

Conditions Studied

Interventions

  • OTHER Individual patient interview, focus group and structured survey
  • OTHER interview, focus group and structured survey

Study Locations (1)

Tennessee

  • Vanderbilt-Ingam Cancer Center - Nashville

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2006-01
Est. Completion 2008-03

Sponsor

Vanderbilt-Ingram Cancer Center

189 total trials

What the Registry Record Tells You About NCT01230515

The ClinicalTrials.gov registry entry for NCT01230515 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 158-participant average among 15 other Cancer Pain trials with a reported enrollment target (59% lower). The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer Pain appearing as the primary indexed condition, and to 2 interventions - of which Individual patient interview, focus group and structured survey is the first listed.

NCT01230515 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.

Frequently Asked Questions

What is clinical trial NCT01230515 about?

NCT01230515 is a clinical study titled "Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol". The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive preliminary efficacy data.

What is the current status of trial NCT01230515?

This trial is currently completed. The enrollment target is 65 participants. The study started on 2006-01. Estimated completion is 2008-03.

What conditions does trial NCT01230515 study?

This clinical trial studies the following conditions: Cancer Pain.

What interventions are being tested in trial NCT01230515?

The interventions under investigation include: Individual patient interview, focus group and structured survey (OTHER), interview, focus group and structured survey (OTHER).

Who is sponsoring clinical trial NCT01230515?

This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01230515 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.